Catheter-Based Mechanical Thrombectomy Associated with Reduced Chronic Thromboembolic Pulmonary Hypertension Risk

Article Impact Level: HIGH
Data Quality: STRONG
Summary of  Journal of the Society for Cardiovascular Angiography & Interventions https://doi.org/10.1016/j.jscai.2026.105753
Dr. Mahmoud Ismayl et al.

Points

Mayo Clinic researchers conducted a systematic review and meta analysis analyzing twelve studies comprising four thousand two hundred sixty eight patients with intermediate risk pulmonary embolism.
Of the overall cohort fourty four percent representing one thousand eight hundred seventy eight patients underwent endovascular mechanical thrombectomy compared to standard anticoagulation alone.
Primary pooled analyses established that mechanical thrombectomy was associated with significantly lower thirty day one year and two year mortality compared to conservative anticoagulation.
Sensitivity analyses restricted strictly to intermediate risk cohorts confirmed a persistent statistically significant reduction in the risk of developing chronic thromboembolic pulmonary hypertension.
Authors concluded that mechanical thrombectomy expands therapeutic options for intermediate risk pulmonary embolism but emphasized that prospective randomized controlled trials are essential for validation.

Summary

This systematic review and meta-analysis evaluated the safety and therapeutic efficacy of mechanical thrombectomy (MT) compared with anticoagulation alone in patients with intermediate-risk pulmonary embolism. Simultaneously published in the Journal of the Society for Cardiovascular Angiography & Interventions and presented at TCT 2026 by Mayo Clinic researchers led by Dr. Mahmoud Ismayl, the investigation addressed the ongoing clinical debate surrounding invasive endovascular intervention versus standard systemic anticoagulation in submassive pulmonary embolism. Given that intermediate-risk pulmonary embolism carries significant risks of acute hemodynamic decompensation and long-term right ventricular dysfunction, the research sought to synthesize available evidence on short-term mortality, long-term survival, and chronic thromboembolic pulmonary hypertension (CTEPH) incidence.

The meta-analysis incorporated 12 studies comprising a total cohort of 4,268 patients with intermediate-risk pulmonary embolism, of whom 1,878 (44%) underwent catheter-based mechanical thrombectomy. In the primary analysis, mechanical thrombectomy was associated with significantly lower 30-day, 1-year, and 2-year all-cause mortality compared to anticoagulation alone, as well as a statistically significant reduction in the development of chronic thromboembolic pulmonary hypertension. However, in a sensitivity analysis restricted exclusively to studies enrolling intermediate-risk cohorts, 30-day mortality was similar between treatment arms, while the reduction in CTEPH risk maintained statistical significance; 1-year and 2-year sensitivity estimates could not be pooled due to single-study reporting constraints for each time point.

The authors conclude that mechanical thrombectomy is associated with reduced short- and long-term mortality and lower rates of future CTEPH compared with anticoagulation alone in intermediate-risk pulmonary embolism. While these observational associations support mechanical thrombectomy as a promising therapeutic strategy, the authors emphasize that large-scale randomized controlled trials are urgently needed to confirm these survival benefits and refine patient selection criteria.

Link to the article: https://www.jscai.org/article/S2772-9303(26)01500-0/fulltext

References

Ismayl, M., Ahmed, H., Prokop, L., Ingraham, B. S., & Motiei, A. (2026). Mechanical thrombectomy versus anticoagulation alone for intermediate-risk pulmonary embolism: A systematic review and meta-analysis. Journal of the Society for Cardiovascular Angiography & Interventions, 105753. https://doi.org/10.1016/j.jscai.2026.105753